October 2, 2017 Clinical Trials in Psoriatic Disease Webinar
Please join Andrew Blauvelt, M.D., MBA, as he discusses clinical trials in psoriatic diseases.
Monday, October 2, 2017 4:00 p.m. Pacific / 6:00 p.m. Central / 7:00 p.m. Eastern
Register Here, through GoToWebinar to attend this live 1.0 hour CME-accredited educational webinar.
Unable to attend the webinar during the specified time? Watch it as an enduring material! All webinars will be posted for a period of two years following its live session.
This program is supported by unrestricted educational grants from Eli Lilly & Company, Celgene Corporation, Valeant Pharmaceuticals North America, LLC and Dermira Inc..
The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Psoriasis Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Dermatologists, Rheumatologists, Allied Health, Primary Care
- Identify resources and best practices for recruiting and communicating with participants
- Identify and respond to common questions and concerns patients may have about participating in a clinical trial to ensure informed consent is a shared decision making process
- Utilize best practices in preparing for and implementing a psoriatic disease clinical trial in their practice
- Identify resources and information necessary to keep abreast of relevant clinical trials and confidently screen and recommend potential patients for participation.